Trials / Completed
CompletedNCT06560892
Comparison of Intraperitoneal Bupivacaine Alone or With Dexmedetomidine
Comparison Between Mean Duration of Post-operative Analgesia of Intraperitoneal Bupivacaine Alone or With Dexmedetomidine Following Laparoscopic Cholecystectomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- RESnTEC, Institute of Research · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
For patients with symptomatic cholelithiasis, laparoscopic cholecystectomy (LC) is a customary procedure for treatment these days. After LC, patients may experience considerable pain. This study was performed with the objective of comparing the mean duration of analgesia of intraperitoneal bupivacaine with dexmedetomidine to intraperitoneal bupivacaine alone in patients undergoing laparoscopic cholecystectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupivacaine injection | patients received intraperitoneal bupivacaine 50 ml 0.25% + 5 ml normal saline. |
| DRUG | Dexmedetomidine injection | Patients were given intraperitoneal bupivacaine 50 ml 0.25% + dexmedetomidine 1 μg/kg with normal saline 5 ml. |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-06-30
- Completion
- 2024-06-30
- First posted
- 2024-08-19
- Last updated
- 2024-08-21
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06560892. Inclusion in this directory is not an endorsement.